| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 71.89× | 71.89× | 65.10× | 63.35× | 62.94× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −26.90× | −13.34× | −39.00× | −61.23× | −39.78× | ||
| 1.11× | 1.11× | 1.14× | 1.08× | 1.06× | ||
| 1.80× | 1.80× | 1.18× | 1.25× | 1.55× | ||
| 0.78× | 0.78× | 0.58× | 0.67× | 0.96× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 62.94 | 63.35 | 65.10 | 71.89 | 71.89 | |
| Working Capital Turnover | -39.78 | -61.23 | -39.00 | -13.34 | -26.90 | |
| Asset Turnover | 1.06 | 1.08 | 1.14 | 1.11 | 1.11 | |
| Cash Conversion (CFO/Net Income) | 1.55 | 1.25 | 1.18 | 1.80 | 1.80 | |
| CFO/EBITDA | 0.96 | 0.67 | 0.58 | 0.78 | 0.78 |